{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:04:17Z","timestamp":1790726657225,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rpth.2026.103419","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:48:57Z","timestamp":1774658937000},"page":"103419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuous vs interrupted direct oral anticoagulants for minimal bleeding-risk surgical procedures\u2014a systematic review and meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-1319","authenticated-orcid":false,"given":"Alexander","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil","family":"Popatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Lopes","family":"Sadafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrad","family":"Nowrouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Eshaghpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103419_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2026.103419_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2024.12708","article-title":"Perioperative management of patients taking direct oral anticoagulants: a review","volume":"332","author":"Douketis","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.103419_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-0036-1597831","article-title":"Reversal of direct oral anticoagulants: current status and future directions","volume":"38","author":"Weitz","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.rpth.2026.103419_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.thromres.2020.08.016","article-title":"Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review","volume":"194","author":"Li","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103419_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jth.13305","article-title":"Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery","volume":"14","author":"Spyropoulos","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103419_bib6","doi-asserted-by":"crossref","DOI":"10.52965\/001c.115605","article-title":"Perioperative management of traditional and direct oral anticoagulants in hip fracture patients","volume":"16","author":"Sachdev","year":"2024","journal-title":"Orthop Rev (Pavia)"},{"key":"10.1016\/j.rpth.2026.103419_bib7","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.103419_bib8","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2026.103419_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2200322","article-title":"Perioperative management of anticoagulant and antiplatelet therapy","volume":"2","author":"Douketis","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.rpth.2026.103419_bib10","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1053\/j.jvca.2022.07.016","article-title":"Perioperative management of direct oral anticoagulants in cardiac surgery: practice recommendations based on current evidence","volume":"36","author":"Budd","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.rpth.2026.103419_bib11","first-page":"329","article-title":"Management of DOAC in patients undergoing planned surgery or invasive procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper","volume":"122","author":"Squizzato","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103419_bib12","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2026.103419_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jce.15043","article-title":"Uninterrupted versus interrupted direct oral anticoagulation for catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"32","author":"Asad","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib14","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103419_bib15","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.rpth.2026.103419_bib16","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.103419_bib17","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.103419_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.103419_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.103419_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/clc.22726","article-title":"Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation","volume":"40","author":"Black-Maier","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.rpth.2026.103419_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10792-018-0862-x","article-title":"Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications","volume":"39","author":"Cheung","year":"2019","journal-title":"International ophthalmology"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.103419_bib22","article-title":"Efficacy and risk of therapy with the vitamin K antagonist phenprocoumone compared to direct oral anticoagulants in catheter ablation of atrial fibrillation","volume":"140","author":"Gjermeni","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.103419_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00784-018-2458-2","article-title":"Bleeding related to dental treatment in patients taking novel oral anticoagulants (NOACs): a retrospective study","volume":"23","author":"Kwak","year":"2019","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.rpth.2026.103419_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ijom.2018.03.009","article-title":"Assessing an oral surgery specific protocol for patients on direct oral anticoagulants: a retrospective controlled cohort study","volume":"47","author":"Lababidi","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.rpth.2026.103419_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/odi.12698","article-title":"Direct oral anticoagulants: a retrospective study of bleeding, behavior, and documentation","volume":"24","author":"Miller","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.rpth.2026.103419_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/joa3.12655","article-title":"Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation","volume":"38","author":"Osawa","year":"2022","journal-title":"J Arrhythm"},{"key":"10.1016\/j.rpth.2026.103419_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2021.04.006","article-title":"Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures","volume":"203","author":"Sheikh","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103419_bib28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1536\/ihj.19-143","article-title":"Feasibility of uninterrupted direct oral anticoagulants with temporary switching to dabigatran (\u201cdabigatran bridge\u201d) for catheter ablation of atrial fibrillation","volume":"60","author":"Aoyama","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.rpth.2026.103419_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jacep.2023.08.037","article-title":"DOACs vs vitamin K antagonists during cardiac rhythm device surgery: a multicenter propensity-matched study","volume":"10","author":"Creta","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/dj12090279","article-title":"Direct oral anticoagulants and bleeding management following tooth extractions\u2014a prospective cohort study","volume":"12","author":"Izzetti","year":"2024","journal-title":"Dent J (Basel)"},{"key":"10.1016\/j.rpth.2026.103419_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10840-016-0117-6","article-title":"Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation","volume":"46","author":"Muller","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jjcc.2019.02.003","article-title":"Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation","volume":"74","author":"Nakamura","year":"2019","journal-title":"J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.103419_bib33","article-title":"Post-ablation cerebral thromboembolisms in balloon-based ablation of atrial fibrillation with periprocedural direct oral anticoagulants: a comparison between cryoballoon and hotballoon ablation","volume":"138","author":"Nakamura","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.103419_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10840-020-00718-w","article-title":"Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants","volume":"60","author":"Petzl","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2021.05.020","article-title":"Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study","volume":"91","author":"van der Wall","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rpth.2026.103419_bib36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00380-019-01370-9","article-title":"Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study","volume":"34","author":"Ando","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.rpth.2026.103419_bib37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/europace\/euy224","article-title":"Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy","volume":"21","author":"Nagao","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.rpth.2026.103419_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euy148","article-title":"Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events","volume":"21","author":"Nakamura","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.rpth.2026.103419_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","article-title":"A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial","volume":"4","author":"Reynolds","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib40","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/pace.13482","article-title":"Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: a single-center randomized prospective pilot trial","volume":"41","author":"Ricciardi","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib41","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/jce.14260","article-title":"Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes","volume":"30","author":"Yamaji","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib42","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/eurheartj\/ehy870","article-title":"When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study","volume":"40","author":"Yu","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2026.103419_bib43","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"Andexanet for factor Xa inhibitor\u2013associated acute intracerebral hemorrhage","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103419_bib44","article-title":"Evaluation of factors underlying differences in venous thromboembolism rates between Black and White patients","volume":"13","author":"Lin","year":"2025","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.103419_bib45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/pace.14091","article-title":"Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: a systematic review","volume":"43","author":"Mendoza","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.rpth.2026.103419_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/joa3.12507","article-title":"Outcomes of uninterrupted vs interrupted periprocedural direct oral anticoagulants in atrial fibrillation ablation: a meta-analysis","volume":"37","author":"Basu-Ray","year":"2021","journal-title":"J Arrhythm"},{"key":"10.1016\/j.rpth.2026.103419_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijcard.2018.03.095","article-title":"Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: an updated meta-analysis","volume":"262","author":"Ha","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.rpth.2026.103419_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12959-025-00686-z","article-title":"Balancing the risks: continuous vs. interrupted anticoagulation during TAVI\u2014what does the evidence say?","volume":"23","author":"Patel","year":"2025","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2026.103419_bib49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jce.12608","article-title":"Silent cerebral events\/lesions related to atrial fibrillation ablation: a clinical review","volume":"26","author":"Deneke","year":"2015","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:17:51Z","timestamp":1790723871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2475037926000774"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103419","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous vs interrupted direct oral anticoagulants for minimal bleeding-risk surgical procedures\u2014a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103419"}}